• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过外周循环微小RNA建模进行乳腺癌识别

Breast cancer identification via modeling of peripherally circulating miRNAs.

作者信息

Cui Xiaomeng, Li Zhangming, Zhao Yilei, Song Anqi, Shi Yunbo, Hai Xin, Zhu Wenliang

机构信息

The higher educational key laboratory for Measuring & Control Technology and Instrumentations of Heilongjiang Province, Harbin, China.

School of Measurement-Control Tech & Communications Engineering, Harbin University of Science and Technology, Harbin, China.

出版信息

PeerJ. 2018 Mar 26;6:e4551. doi: 10.7717/peerj.4551. eCollection 2018.

DOI:10.7717/peerj.4551
PMID:29607263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5875392/
Abstract

Prolonged life expectancy in humans has been accompanied by an increase in the prevalence of cancers. Breast cancer (BC) is the leading cause of cancer-related deaths. It accounts for one-fourth of all diagnosed cancers and affects one in eight females worldwide. Given the high BC prevalence, there is a practical need for demographic screening of the disease. In the present study, we re-analyzed a large microRNA (miRNA) expression dataset (GSE73002), with the goal of optimizing miRNA biomarker selection using neural network cascade (NNC) modeling. Our results identified numerous candidate miRNA biomarkers that are technically suitable for BC detection. We combined three miRNAs (miR-1246, miR-6756-5p, and miR-8073) into a single panel to generate an NNC model, which successfully detected BC with 97.1% accuracy in an independent validation cohort comprising 429 BC patients and 895 healthy controls. In contrast, at least seven miRNAs were merged in a multiple linear regression model to obtain equivalent diagnostic performance (96.4% accuracy in the independent validation set). Our findings suggested that suitable modeling can effectively reduce the number of miRNAs required in a biomarker panel without compromising prediction accuracy, thereby increasing the technical possibility of early detection of BC.

摘要

人类预期寿命的延长伴随着癌症患病率的增加。乳腺癌(BC)是癌症相关死亡的主要原因。它占所有确诊癌症的四分之一,全球每八名女性中就有一人受其影响。鉴于乳腺癌的高患病率,实际需要对该疾病进行人群筛查。在本研究中,我们重新分析了一个大型微小RNA(miRNA)表达数据集(GSE73002),目的是使用神经网络级联(NNC)建模优化miRNA生物标志物的选择。我们的结果确定了许多在技术上适合乳腺癌检测的候选miRNA生物标志物。我们将三种miRNA(miR-1246、miR-6756-5p和miR-8073)组合成一个单一的检测组以生成一个NNC模型,该模型在一个由429名乳腺癌患者和895名健康对照组成的独立验证队列中以97.1%的准确率成功检测出乳腺癌。相比之下,在多元线性回归模型中合并了至少七种miRNA以获得同等的诊断性能(独立验证集中的准确率为96.4%)。我们的研究结果表明,合适的建模可以有效减少生物标志物检测组中所需的miRNA数量,而不会影响预测准确性,从而增加乳腺癌早期检测的技术可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc1/5875392/f13fd9579f0b/peerj-06-4551-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc1/5875392/313c0938eb64/peerj-06-4551-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc1/5875392/901a45ad183c/peerj-06-4551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc1/5875392/f13fd9579f0b/peerj-06-4551-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc1/5875392/313c0938eb64/peerj-06-4551-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc1/5875392/901a45ad183c/peerj-06-4551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc1/5875392/f13fd9579f0b/peerj-06-4551-g003.jpg

相似文献

1
Breast cancer identification via modeling of peripherally circulating miRNAs.通过外周循环微小RNA建模进行乳腺癌识别
PeerJ. 2018 Mar 26;6:e4551. doi: 10.7717/peerj.4551. eCollection 2018.
2
Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.X 染色体上 miR-106a-363 簇的循环 microRNAs 作为乳腺癌的新型诊断生物标志物。
Breast Cancer Res Treat. 2018 Jul;170(2):257-270. doi: 10.1007/s10549-018-4757-3. Epub 2018 Mar 20.
3
Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.乳腺癌患者尿液中微小RNA检测的可行性及其作为一种创新型非侵入性生物标志物的潜力。
BMC Cancer. 2015 Mar 28;15:193. doi: 10.1186/s12885-015-1190-4.
4
Candidate miRNAs in human breast cancer biomarkers: a systematic review.人类乳腺癌生物标志物中的候选 miRNA:系统评价。
Breast Cancer. 2018 Mar;25(2):198-205. doi: 10.1007/s12282-017-0814-8. Epub 2017 Nov 3.
5
Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.基于微小RNA谱分析鉴定乳腺癌患者血液中的微小RNA生物标志物。
Gene. 2017 Jul 1;619:10-20. doi: 10.1016/j.gene.2017.03.038. Epub 2017 Mar 27.
6
Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.血浆 microRNAs 作为早期胃癌早期检测的潜在新型生物标志物。
World J Gastroenterol. 2019 Apr 7;25(13):1580-1591. doi: 10.3748/wjg.v25.i13.1580.
7
microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection.对个体乳腺癌患者的微小RNA表达谱分析确定了用于早期检测的新型循环微小RNA组合。
Sci Rep. 2016 May 16;6:25997. doi: 10.1038/srep25997.
8
MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.配对的原发性和淋巴结转移性乳腺癌的MicroRNA表达谱分析揭示了与淋巴结转移相关的独特MicroRNA谱。
Front Oncol. 2020 May 19;10:756. doi: 10.3389/fonc.2020.00756. eCollection 2020.
9
A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.一种循环miRNA特征作为乳腺癌非侵入性早期检测的诊断生物标志物。
Breast Cancer Res Treat. 2015 Nov;154(2):423-34. doi: 10.1007/s10549-015-3591-0. Epub 2015 Oct 17.
10
A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.血浆中七种 miRNA 特征组成的 panel 作为结直肠癌诊断的潜在生物标志物。
Gene. 2019 Mar 1;687:246-254. doi: 10.1016/j.gene.2018.11.055. Epub 2018 Nov 17.

引用本文的文献

1
Circulating microRNA panels for multi-cancer detection and gastric cancer screening: leveraging a network biology approach.用于多癌检测和胃癌筛查的循环微小RNA检测板:利用网络生物学方法
BMC Med Genomics. 2025 Feb 6;18(1):27. doi: 10.1186/s12920-025-02091-x.
2
Impact of dcEF on microRNA profiles in glioblastoma and exosomes using a novel microfluidic bioreactor.使用新型微流控生物反应器研究直流电刺激电场对胶质母细胞瘤和外泌体中微小RNA谱的影响。
Biomicrofluidics. 2024 Dec 27;18(6):064106. doi: 10.1063/5.0228901. eCollection 2024 Dec.
3
Personalized treatment approach for HER2-positive metastatic breast cancer.

本文引用的文献

1
miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.miR-27b-3p 通过靶向乳腺癌细胞中的 CBLB/GRB2 抑制增殖并可能逆转多药耐药性。
Cell Death Dis. 2018 Feb 7;9(2):188. doi: 10.1038/s41419-017-0211-4.
2
An ultrasensitive detection of miRNA-155 in breast cancer via direct hybridization assay using two-dimensional molybdenum disulfide field-effect transistor biosensor.基于二维二硫化钼场效应晶体管生物传感器的杂交直接检测法用于乳腺癌中 miRNA-155 的超灵敏检测
Biosens Bioelectron. 2018 May 15;105:6-13. doi: 10.1016/j.bios.2018.01.009. Epub 2018 Jan 6.
3
针对人表皮生长因子受体 2(HER2)阳性转移性乳腺癌的个体化治疗方法。
Med Oncol. 2024 Sep 25;41(11):252. doi: 10.1007/s12032-024-02504-4.
4
Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer.鉴定血清 miR-1246 和 miR-150-5p 作为高级别浆液性卵巢癌的新型诊断生物标志物。
Sci Rep. 2023 Nov 7;13(1):19287. doi: 10.1038/s41598-023-45317-7.
5
Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.miR-4442 在结直肠癌中的作用:预测早期复发和调节上皮-间充质转化。
Genes (Basel). 2023 Jul 8;14(7):1414. doi: 10.3390/genes14071414.
6
Deep Learning Based Methods for Breast Cancer Diagnosis: A Systematic Review and Future Direction.基于深度学习的乳腺癌诊断方法:系统综述与未来方向
Diagnostics (Basel). 2023 Jan 3;13(1):161. doi: 10.3390/diagnostics13010161.
7
Extracellular Vesicle MicroRNA in Malignant Pleural Effusion.恶性胸腔积液中的细胞外囊泡 microRNA。
Genes (Basel). 2022 Nov 19;13(11):2159. doi: 10.3390/genes13112159.
8
Potential utility of miRNAs for liquid biopsy in breast cancer.微小RNA在乳腺癌液体活检中的潜在应用价值
Front Oncol. 2022 Aug 4;12:940314. doi: 10.3389/fonc.2022.940314. eCollection 2022.
9
Isolation and Characterization of Urinary Extracellular Vesicles from Healthy Donors and Patients with Castration-Resistant Prostate Cancer.从健康供体和去势抵抗性前列腺癌患者中分离和表征尿细胞外囊泡。
Int J Mol Sci. 2022 Jun 27;23(13):7134. doi: 10.3390/ijms23137134.
10
Current and Developing Liquid Biopsy Techniques for Breast Cancer.乳腺癌的当前及发展中的液体活检技术
Cancers (Basel). 2022 Apr 19;14(9):2052. doi: 10.3390/cancers14092052.
Constructing an ovarian cancer metastasis index by dissecting medical records.
通过剖析病历构建卵巢癌转移指数。
Oncotarget. 2017 Nov 6;8(60):102212-102222. doi: 10.18632/oncotarget.22336. eCollection 2017 Nov 24.
4
Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer.外泌体微小RNA miR-1246通过靶向CCNG2促进乳腺癌细胞增殖、侵袭及耐药
Cell Physiol Biochem. 2017;44(5):1741-1748. doi: 10.1159/000485780. Epub 2017 Dec 6.
5
Risk Factors and Preventions of Breast Cancer.乳腺癌的风险因素与预防。
Int J Biol Sci. 2017 Nov 1;13(11):1387-1397. doi: 10.7150/ijbs.21635. eCollection 2017.
6
Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis.医学检查揭示 miR-194-5p 可作为绝经后骨质疏松症的生物标志物。
Sci Rep. 2017 Dec 1;7(1):16726. doi: 10.1038/s41598-017-17075-w.
7
Epidemiology of gynecologic cancers in China.中国妇科癌症的流行病学。
J Gynecol Oncol. 2018 Jan;29(1):e7. doi: 10.3802/jgo.2018.29.e7.
8
Breast Cancer: Multiple Subtypes within a Tumor?乳腺癌:肿瘤内存在多种亚型?
Trends Cancer. 2017 Nov;3(11):753-760. doi: 10.1016/j.trecan.2017.09.001. Epub 2017 Oct 24.
9
MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.miR-128 对三阴性乳腺癌葡萄糖代谢和细胞增殖的调控作用。
Br J Surg. 2018 Jan;105(1):75-85. doi: 10.1002/bjs.10646. Epub 2017 Nov 8.
10
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.循环 microRNAs 在乳腺癌中的作用:新型诊断和预后生物标志物。
Cell Death Dis. 2017 Sep 7;8(9):e3045. doi: 10.1038/cddis.2017.440.